Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease.

Abstract : BACKGROUND: Inflammatory bowel disease constitutes a heterogeneous group of conditions, whose aetiology is only partly understood. The prevailing hypothesis on its pathogenesis is that IBD is the result of an inadequate immune response to the resident bacterial flora of the intestine. An autoimmune background, however, has been discussed since the 1950s. Lately, it has been shown that failures in interleukin-10 (IL-10) signalling due to IL-10- and IL-10 receptor (IL-10R) mutations result in IBD. Our study aimed at investigating the existence of inhibitory autoantibodies against IL-10 and IL-10R in IBD patients capable of down-modulating IL-10 signalling thereby mimicking IL-10 or IL-10R deficiency. RESULTS: Thirteen IBD patients had IgG autoantibodies against IL-10, IL-10RA and/or IL-10RB, and three patients had IgA autoantibodies against IL-10. However, the absolute OD values of the serum antibodies measured by ELISA were low, there was overall no significant difference between patients and controls, and positive sera had no neutralizing activity. CONCLUSION: No evidence for an involvement of autoantibodies against IL-10 or IL-10R in the pathogenesis of inflammatory bowel disease could be established.
Type de document :
Article dans une revue
BMC Immunology, BioMed Central, 2014, 15 (1), pp.10. 〈10.1186/1471-2172-15-10〉
Liste complète des métadonnées

Littérature citée [30 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00955829
Contributeur : Ed. Bmc <>
Soumis le : mercredi 5 mars 2014 - 13:07:09
Dernière modification le : mercredi 6 décembre 2017 - 01:17:54
Document(s) archivé(s) le : jeudi 5 juin 2014 - 11:20:57

Fichiers

Identifiants

Collections

Citation

Natalie Frede, Erik-Oliver Glocker, Jennifer Wanders, Karin Engelhardt, Wolfgang Kreisel, et al.. Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease.. BMC Immunology, BioMed Central, 2014, 15 (1), pp.10. 〈10.1186/1471-2172-15-10〉. 〈inserm-00955829〉

Partager

Métriques

Consultations de la notice

1043

Téléchargements de fichiers

262